Balanced news tone
News Sentiment
RO sentiment intelligence
Roche Holding AG news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
53
Balanced news tone
11 relevant articles
News tone and price action are not far from neutral.
95/100 classification confidence.
directly relevant articles
high-authority source matches
+0.5% over one week, +0.7% over four weeks, trend inactive, and near fair-value range.
Risdiplam generic drug case: SC rejects Roche plea against Natco pharma
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
95/100 classification
One-week reaction
0.5%
Price digesting
Trend fit
Trend inactive
0.7% over four weeks
Fair value
22.2%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
2
Neutral
9
Negative
0
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Business Standard
Direct company coverage
Risdiplam generic drug case: SC rejects Roche plea against Natco pharma
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Oct 2025 07:00
- Source
- Business Standard
Business Standard
Direct company coverage
Natco Pharma up 6% as Delhi HC clears SMA drug, rejects Roche appeal
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Oct 2025 07:00
- Source
- Business Standard
European Biotechnology Magazine
Direct company coverage
Roche acquires 89bio for US$3.5bn
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Sep 2025 07:00
- Source
- European Biotechnology Magazine
Inside INdiana Business
Direct company coverage
Roche picks Indiana for new plant, expanded operations as part of $50B investment
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Apr 2025 07:00
- Source
- Inside INdiana Business
The Motley Fool
Direct company coverage
Which Is the Better Long-Term Hold for Investors: Pfizer or Roche?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Oct 2023 07:00
- Source
- The Motley Fool
The Motley Fool
Direct company coverage
Is Roche a Buy Now?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 20 Mar 2023 07:00
- Source
- The Motley Fool
thestreet.com
Direct company coverage
Gilead Sciences Names Roche's O'Day as CEO and Chairman
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Dec 2018 08:00
- Source
- thestreet.com
CNBC
Direct company coverage
Roche agrees to pay $2.4 billion to buy the rest of Foundation Medicine
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 19 Jun 2018 07:00
- Source
- CNBC
BioPharma Dive
Direct company coverage
Roche reports deaths of patients taking Hemlibra
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Mar 2018 07:00
- Source
- BioPharma Dive
BioSpace
Direct company coverage
Tips on How to Get Hired From Roche
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Oct 2017 07:00
- Source
- BioSpace
Costa Rica Star News
Direct company coverage
Transnational Roche Selects Escazú Village to House Costa Rican IT Service Center
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Sep 2017 01:13
- Source
- Costa Rica Star News